Replication-incompetent GM-CSF-expressing gene-modified allogeneic acute myeloid leukemia cancer cell lines

Replication-incompetent GM-CSF-expressing gene-modified allogeneic acute myeloid leukemia cancer cell lines
Trade Name Gvax Acute Myeloid Leukemia
Orphan Indication Acute myeloid leukemia
USA Market Approval USA
USA Designation Date 2010-03-02 00:00:00
Sponsor Aduro BioTech, Inc.;740 Heinz Avenue;Berkeley, California, 94710
Related Access Program
Children’s Hospital Los Angeles – Acute myeloid leukemia Jazz Pharmaceuticals – Secondary AML Celator Pharmaceuticals – Secondary AML University of California, San Francisco – Acute myeloid leukemia Emory University – Acute myeloid leukemia